Search research articles
Contact Us
Filters
Showing results (311-320 of 651) with videos related to
Page
of 66
Sort By:
Blood
|
November 13, 2004
RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation
Joachim Schwäble, Chunaram Choudhary, Christian Thiede, et al.
Oncogene
|
April 15, 2005
Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells
Ping Ji, Shuchi Agrawal, Sven Diederichs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer
Jun Yu, Etmar Bulk, Ping Ji, et al.
Blood
|
December 4, 2013
Suboptimal dosing of rituximab in male and female patients with DLBCL
Michael Pfreundschuh, Carsten Müller, Samira Zeynalova, et al.
Science Advances
|
September 29, 2021
Novel synthetic pathway for the production of phosgene
Patrick Voßnacker, Alisa Wüst, Thomas Keilhack, et al.
International Journal of Molecular Medicine
|
June 2, 2023
Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells
Franziska Eberhardt, Angela Hückelhoven-Krauss, Alexander Kunz, et al.
Molecular Therapy. Methods & Clinical Development
|
March 24, 2020
Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients
Alexander Kunz, Ulrike Gern, Anita Schmitt, et al.
International Journal of Cancer
|
May 9, 2024
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies
Maike Janssen, Albrecht Leo, Cornelia Wolf, et al.
Blood Advances
|
September 29, 2021
An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies
Tobias Roider, Berit J Brinkmann, Vladislav Kim, et al.
Frontiers in Oncology
|
May 8, 2023
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma
Lukas John, Kaya Miah, Axel Benner, et al.
Page
of 66
Search research articles
Search
Showing results (311-320 of 651) with videos related to
Sort By:
Page
of 66
Blood
|
November 13, 2004
RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation
Joachim Schwäble, Chunaram Choudhary, Christian Thiede, et al.
Oncogene
|
April 15, 2005
Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells
Ping Ji, Shuchi Agrawal, Sven Diederichs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer
Jun Yu, Etmar Bulk, Ping Ji, et al.
Blood
|
December 4, 2013
Suboptimal dosing of rituximab in male and female patients with DLBCL
Michael Pfreundschuh, Carsten Müller, Samira Zeynalova, et al.
Science Advances
|
September 29, 2021
Novel synthetic pathway for the production of phosgene
Patrick Voßnacker, Alisa Wüst, Thomas Keilhack, et al.
International Journal of Molecular Medicine
|
June 2, 2023
Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells
Franziska Eberhardt, Angela Hückelhoven-Krauss, Alexander Kunz, et al.
Molecular Therapy. Methods & Clinical Development
|
March 24, 2020
Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients
Alexander Kunz, Ulrike Gern, Anita Schmitt, et al.
International Journal of Cancer
|
May 9, 2024
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies
Maike Janssen, Albrecht Leo, Cornelia Wolf, et al.
Blood Advances
|
September 29, 2021
An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies
Tobias Roider, Berit J Brinkmann, Vladislav Kim, et al.
Frontiers in Oncology
|
May 8, 2023
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma
Lukas John, Kaya Miah, Axel Benner, et al.
Page
of 66